ÂÜÀòÂÒÂ×

Kris Kemeny is the Founder and Managing Director of Tekfen Ventures, a firm established in 2016 that invests in entrepreneurs leveraging technology and science to create innovative solutions for the future. In addition to leading Tekfen Ventures, Kris Kemeny serves as an investor and board observer for multiple companies, including Phospholutions, Inc., Pivot Bio, Tropic Biosciences, Soft Robotics Inc., Claroty, and Sight Machine. Kris Kemeny also invests in Laverock Therapeutics, with a history of involvement with Avvir and Prospera Technologies. Educational qualifications include an MBA from Columbia Business School and a BA in Economics, International Relations, and Political Science from the University of Southern California, along with studies at The London School of Economics and Political Science (LSE).